Amicus Therapeutics to raise $225M in debt offering
Perspectivas América Latina 2023 Emerging Trends & Growth
Insight Weekly: SVB fallout limited; US rents up; renewable natural gas investments flow in
A Cloud Migration Plan for Corporations featuring Snowflake®
Investor Activism Campaigns Hit Record High in 2022
Amicus Therapeutics Inc. announced a $225 million note offering to refinance a part of its existing debt.
The company plans to issue unsecured convertible notes due 2023 in a private placement with an option to purchase an additional $25 million worth of the debt.
The debt will be priced at a later date.
